Coya Therapeutics, Common Stock Market Value
| COYA Stock | 6.08 0.22 3.75% |
| Symbol | Coya |
Coya Therapeutics, Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coya Therapeutics,. If investors know Coya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coya Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Coya Therapeutics, Common is measured differently than its book value, which is the value of Coya that is recorded on the company's balance sheet. Investors also form their own opinion of Coya Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Coya Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coya Therapeutics,'s market value can be influenced by many factors that don't directly affect Coya Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coya Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Coya Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coya Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coya Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coya Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coya Therapeutics,.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in Coya Therapeutics, on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Coya Therapeutics, Common or generate 0.0% return on investment in Coya Therapeutics, over 30 days. Coya Therapeutics, is related to or competes with Cue Biopharma, Lantern Pharma, Fennec Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, Terns Pharmaceuticals, and Day One. Coya Therapeutics, is entity of United States More
Coya Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coya Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coya Therapeutics, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 41.4 | |||
| Value At Risk | (7.20) | |||
| Potential Upside | 7.72 |
Coya Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coya Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coya Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Coya Therapeutics, historical prices to predict the future Coya Therapeutics,'s volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (0.88) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coya Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Coya Therapeutics, Common Backtested Returns
Coya Therapeutics, Common secures Sharpe Ratio (or Efficiency) of -0.0423, which signifies that the company had a -0.0423 % return per unit of risk over the last 3 months. Coya Therapeutics, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Coya Therapeutics,'s Standard Deviation of 5.35, mean deviation of 3.31, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Coya Therapeutics,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Coya Therapeutics, is expected to be smaller as well. At this point, Coya Therapeutics, Common has a negative expected return of -0.14%. Please make sure to confirm Coya Therapeutics,'s value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Coya Therapeutics, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.4 |
Poor reverse predictability
Coya Therapeutics, Common has poor reverse predictability. Overlapping area represents the amount of predictability between Coya Therapeutics, time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coya Therapeutics, Common price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Coya Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Coya Therapeutics, Common lagged returns against current returns
Autocorrelation, which is Coya Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Coya Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Coya Therapeutics, returns to help us make a trade decision. For example, suppose you find that Coya Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Coya Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Coya Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Coya Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Coya Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Coya Therapeutics, Lagged Returns
When evaluating Coya Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Coya Therapeutics, stock have on its future price. Coya Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Coya Therapeutics, autocorrelation shows the relationship between Coya Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Coya Therapeutics, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Coya Therapeutics, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Coya Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Coya Therapeutics, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Coya Therapeutics, Common Stock:Check out Coya Therapeutics, Correlation, Coya Therapeutics, Volatility and Coya Therapeutics, Alpha and Beta module to complement your research on Coya Therapeutics,. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Coya Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.